Artwork
iconShare
 
Manage episode 523434817 series 3595408
Content provided by RSNA Podcasts and The Radiological Society of North America. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by RSNA Podcasts and The Radiological Society of North America or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
*]:pointer-events-auto [content-visibility:auto] supports-[content-visibility:auto]:[contain-intrinsic-size:auto_100lvh] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" tabindex="-1" data-turn-id= "request-WEB:cee59b98-0957-4b41-b5d5-47fb322bf09a-2" data-testid= "conversation-turn-6" data-scroll-anchor="true" data-turn= "assistant">

Host Dr. Linda Chu speaks with Dr. Jana Ivanidze and Dr. Rajiv Magge about how molecular imaging is transforming the diagnosis and management of breast cancer brain metastases, with an emphasis on precision and personalized care. Their discussion highlights emerging tools such as advanced PET techniques and liquid biopsy that support earlier detection, guide treatment planning, and shape the future of neuro-oncology. Sponsored by GE HealthCare.

  continue reading

276 episodes